Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
|Videos|October 10, 2016
Zika and Dengue Coinfection: What Do We Know?
Author(s)Contagion Editorial Staff
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains what is currently known about Zika and Dengue coinfection.
Advertisement
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains what is currently known about Zika and Dengue coinfection.
Interview Transcript (slightly modified for readability)
“From what we know now, previous infection with a mosquito-borne virus doesn’t change the susceptibility or the clinical spectrum of illness with Zika virus. The one thing that is a little bit complicated is that it can make [the infection] harder to diagnose. There are two different kinds of tests that are used to diagnose Zika. The first test is actually looking for a part of the virus itself and that test, depending on what specimen is tested, could be [done] a week or two weeks after symptom onset.
The other test measures the body’s response to the infection: the immune response. If you’ve had prior infection with Dengue, in particular, that [infection] can cause this test to be difficult to interpret because some of the same antibodies—the same response from the body—can be the same in both viruses. That’s where there can be cross-reactivity between the body’s response for Dengue and for Zika.”
Advertisement
Related to this article
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
Advertisement
Advertisement